Odonate Therapeutics Inc

ODT NASDAQ
34.40
+1.23
+3.71%
Opening 10:28 07/22 EDT
Open
33.10
Prev Close
33.17
High
34.94
Low
33.10
Volume
27.71K
Avg Vol (3M)
105.92K
52 Week High
37.99
52 Week Low
11.54
% Turnover
0.09%
Market Cap
1.11B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Odonate Therapeutics Inc ODT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).
MORE >

Recently

Name
Price
%Change